Cargando…

Essential m(6)A Methylation Regulator HNRNPC Serves as a Targetable Biomarker for Papillary Renal Cell Carcinoma

m(6)A RNA modification is a common abundant posttranscriptional modification of mRNAs occurring in cancer growth and progression. Accumulated evidence has proved that HNRNPC, which acts as a m(6)A reader, plays an essential role in the promotion of cancer occurrence and development; nevertheless, th...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Jiajin, Wei, Yuang, Miao, Chenkui, Wang, Songbo, Wang, Xiaoyi, Wang, Zengjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9056237/
https://www.ncbi.nlm.nih.gov/pubmed/35502201
http://dx.doi.org/10.1155/2022/9411692
Descripción
Sumario:m(6)A RNA modification is a common abundant posttranscriptional modification of mRNAs occurring in cancer growth and progression. Accumulated evidence has proved that HNRNPC, which acts as a m(6)A reader, plays an essential role in the promotion of cancer occurrence and development; nevertheless, the role of HNRNPC in papillary renal cell carcinoma remained to be discovered. In this study, we comprehensively identified HNRNPC as a hub gene involved in m(6)A modification in pRCC. Then, the expression level, survival outcomes, PPI network, function enrichment, immune cell infiltration, and single-cell analysis were performed. Finally, we found that HNRNPC significantly promoted renal cell carcinoma proliferation and migration in vitro. In conclusion, our work proved that HNRNPC may act as a momentous m(6)A regulator, as well as a potential targetable biomarker for pRCC.